Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Tara Morgan is a pioneering urologic surgeon and researcher whose work sits at the intersection of robotic surgery, artificial intelligence, and renal oncology. Her primary research focuses on advancing minimally invasive techniques—particularly single-port and robotic-assisted procedures—for treating kidney cancer and benign prostatic hyperplasia. Dr. Morgan’s most impactful contribution is her investigation of irreversible electroporation (IRE) for small renal masses, where her 5-year outcomes study (11 citations) demonstrated this nonthermal ablation technology’s potential to overcome the limitations of traditional thermal methods, offering a new frontier in nephron-sparing treatment. She has also made significant strides in surgical education and evaluation, developing multi-task convolutional neural networks to assess robotic-assisted surgery training videos (16 citations), and later expanding this work to real partial nephrectomies using fully convolutional segmentation (4 citations). Her clinical studies on robotic partial nephrectomy for T3a renal masses with venous tumor thrombus (5 citations) and the use of preoperative pharmacologic prophylaxis (2 citations) have directly informed surgical protocols. Notably, Dr. Morgan’s work on MRI-based predictive models for BPH histology (5 citations) and the Clear Cell Likelihood Score for reducing benign pathology rates in CKD patients (2 citations) showcases her commitment to precision medicine. With over 69 citations across her published works, Dr. Morgan is shaping the future of urologic surgery through innovation and data-driven practice.